The literature demonstrates the capability of 18F-FDOPA-PET to differentiate low- from high-grade gliomas as well as the presence of an IDH-mutation, the 1p/19q co-deletion status and the MGMT methylation status. Here, MGMT is linked to central nervous system cancer.